Ultrasonography.  2024 Jan;43(1):15-24. 10.14366/usg.23061.

Application of O-RADS US combined with MV-Flow to diagnose ovarian-adnexal tumors

• Ruan L
• Liu H
• Xiang H
• Ni Y
• Feng Y
• Zhou H
• Qi M

• KMID: 2549922
• DOI: http://doi.org/10.14366/usg.23061

Abstract

Purpose
This study aimed to explore the application of Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US) combined with MV-Flow (Samsung Medison Co., Ltd.) to diagnose ovarian-adnexal masses.
Methods
A total of 112 ovarian-adnexal masses (81 benign and 31 malignant) from 105 consecutive patients were analyzed. The O-RADS US and vascular index from MV-Flow (VI^MV) were measured and compared with the reference standard. O-RADS US and MV-Flow were tested for consistency.
Results
Receiver operating characteristic curves were drawn for O-RADS US, MV-Flow, and their combination. The combined methods had the largest area under the curve (0.955), followed by O-RADS US (0.929) and MV-Flow (0.923). A mass was considered malignant when the O-RADS US classification was 5 and VI^MV was ≥7.15. With this definition, MV-Flow had the highest sensitivity (87.10%), with consistent findings for the combined diagnostic methods and O-RADS US (83.87%). The specificity of the combined diagnostic methods (93.83%) was higher than that of MV-Flow (91.36%). O-RADS US had the lowest specificity (90.12%). The combined diagnostic methods had the highest coincidence rate (91.07%), and MV-Flow (90.18%) had a significantly higher coincidence rate than O-RADS US (88.39%). Both O-RADS US and MV-Flow showed good consistency among different physicians (former kappa, 0.974; latter intraclass correlation coefficient [ICC], 0.986). MV-Flow had a high consistency for the same physician (ICC, 1).
Conclusion
O-RADS US and MV-Flow exhibited good diagnostic efficacy, and their combined diagnostic efficacy was higher than that of each individually. O-RADS US and MV-Flow can improve the diagnosis of benign and malignant ovarian-adnexal masses.

Keyword

Ovarian-adnexal ultrasound reporting and data system; O-RADS US; MV-Flow; VI; Ovarian-adnexal mass